TY - JOUR
T1 - Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk
AU - Miele, Luca
AU - Giorgio, Valentina
AU - Gasbarrini, Antonio
AU - Grieco, Antonio
PY - 2015
Y1 - 2015
N2 - Gut microbiota has been recently established to have a contributory role in the development of cardiometabolic disorders, such as atherosclerosis, obesity, and type 2 diabetes. Growing interest has focused on the modulation of gut microbiota as a therapeutic strategy in cardiovascular diseases and metabolic disorders. In this paper, we have reviewed the impact of gut microbiota on metabolic disorders and cardiovascular disease risk, focusing on the newest findings in this field.
AB - Gut microbiota has been recently established to have a contributory role in the development of cardiometabolic disorders, such as atherosclerosis, obesity, and type 2 diabetes. Growing interest has focused on the modulation of gut microbiota as a therapeutic strategy in cardiovascular diseases and metabolic disorders. In this paper, we have reviewed the impact of gut microbiota on metabolic disorders and cardiovascular disease risk, focusing on the newest findings in this field.
KW - Cardiovascular disease
KW - Gut microbiota
KW - Obesity
KW - Platelets
KW - Type 2 diabetes
KW - Cardiovascular disease
KW - Gut microbiota
KW - Obesity
KW - Platelets
KW - Type 2 diabetes
UR - https://publicatt.unicatt.it/handle/10807/70778
UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84945137850&origin=inward
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84945137850&origin=inward
U2 - 10.1007/s11886-015-0671-z
DO - 10.1007/s11886-015-0671-z
M3 - Article
SN - 1523-3782
VL - 17
SP - 120
EP - 120
JO - Current Cardiology Reports
JF - Current Cardiology Reports
IS - 12
ER -